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Introduction
Cancers of the colon and rectum (colorectal) constitute
a significant proportion of the global burden of cancer
morbidity and mortality, particularly in highly
industrialised countries where these malignancies rank
second in terms of both incidence and mortality, compared
with fifth in less developed countries (Stewart and
Kleihues, 2003). Annually, approximately 1 million new
cases of colorectal cancer are diagnosed, more than 90%
of which occurs among individuals older than 50 years of
age (Parkin et al., 2002; Stewart and Kleihues, 2003).  In
the West, recent improvements in its detection and
management have resulted in a five-year survival rate of
more than 60% (although it remains low, at around 30%
in developing countries) but nevertheless, every year, more
than half a million people die from colorectal cancer,
equivalent to approximately 8% of all cancer-related
deaths worldwide (Parkin et al., 2002; Stewart and
Kleihues, 2003).
The wide geographical variation in incidence rates for
colorectal cancer, combined with reports of increasing
incidence rates in countries that are undergoing rapid
industrialisation (e.g. China), lends support to the theory
that lifestyle risk factors, including diet, physical activity,
obesity and diabetes, play a pivotal role in the aetiology
of the disease (Potter et al., 1993). This is further evidenced
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Abstract
Although colorectal cancer is one of the leading malignancies worldwide, there are few data on aetiological
relationships from the Asia-Pacific region. Therefore, a collaborative study was conducted involving over half a
million subjects from 33 cohort studies in the region. Age-adjusted death rates from colorectal cancer, over an
average of 6.8 years follow-up, were 12 and 14 per 100,000 person-years among Asian women and men,
respectively; corresponding values in Australasia were 31 and 41. Height was strongly associated with death
from colorectal cancer: an extra 5cm of height was associated with 10% (95% confidence interval, 3% - 18%)
additional risk, after adjustment for other factors. Smoking increased risk by 43% (9% - 88%), although no
significant dose-response relationship was discerned (p >0.05). Other significant (p <0.05) risk factors were
body mass index and lack of physical activity. There was no significant effect on colorectal cancer mortality for
alcohol consumption, waist circumference, fasting blood glucose or diabetes, although the latter conferred a
notable 26% additional risk. Height may be a biomarker for some currently unknown genetic, or environmental,
risk factors that are related both to skeletal growth and mutanogenesis. Understanding such mechanisms could
provide opportunities for novel preventive and therapeutic intervention.
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by data from migrant studies which indicates that the
incidence of colorectal cancer increases among groups
migrating from low to high incidence areas within a couple
of generations (Haenszel et al., 1968).
Data from large-scale epidemiological studies, and
from several meta-analyses, have suggested modest
(relative risk less than 2) associations between low levels
of physical activity (Samad et al., 2005), diabetes (Larsson
et al., 2005), obesity (Bianchin et al., 2002) and diets low
in fibre, fruit and vegetables (Terry et al., 2001a; Gonzalez,
2006), with increased risk of colorectal cancer.  The
evidence for a causative role for cigarette smoking in the
aetiology of colorectal cancer is more equivocal than it is
for some of these other risk factors, possibly due to a long
induction period (30-40 years) between the onset of
smoking and the development of the neoplasm that has
previously been postulated (Giovannucci et al., 1994).
To date, most of the studies that have examined the
associations between major lifestyle risk factors and
colorectal cancer have been conducted in populations from
highly-industrialised countries.  Consequently, little is
known about these relationships among populations from
lower- and middle-income countries, particularly those
in Asia. This is of relevance given that large parts of the
region are undergoing rapid economic development and
industrialisation. The primary aim of this study therefore
was to examine the strength and nature of the associations
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between selected lifestyle risk factors with mortality from
colorectal cancer in diverse populations of the Asia Pacific
Region using data from the Asia Pacific Cohort Studies
Collaboration (APCSC).
Materials  and Methods
Details of study identification, data collection and
event verification in the Asia Pacific Cohort Studies
Collaboration (APCSC) are described elsewhere (Zhang
et al., 1999; Woodward et al., 2006).  Briefly, studies were
included if they had continued follow-up for at least 5000
person-years and had recorded vital status at the end of
follow-up. Studies were excluded if entry was dependent
upon a particular condition or risk factor. Mortality was
classified according to the 9th Revision of the International
Classification of Diseases (ICD): Colorectal cancer was
selected as ICD 153 – 154. Studies were classified as Asian
if their participants were recruited from mainland China,
Hong Kong, Japan, Korea, Singapore, Taiwan or Thailand;
and ANZ if from Australia or New Zealand.
All data on cigarette smoking (Woodward et al., 2005)
were based on self-report at the time of entry into one of
the included studies; smoking status was recorded as
current, former or never-smoker. Of these studies, 19
additionally recorded the average number of cigarettes
per day; groups of <20, and ≥20 cigarettes were chosen
as 20 cigarettes corresponds to one standard pack.
At recruitment, information on alcohol consumption
was recorded by some studies but few studies recorded
the amount or type (beer, wine or spirits) of alcohol
consumed.  Hence, alcohol consumption was
dichotomised into: ‘yes’ to indicate current drinkers at
study baseline and ‘no’ to indicate no consumption of
alcoholic beverages.  Similarly, physical activity was
recorded by 14 studies, but studies varied according to
how well it was measured in terms of frequency, type and
duration. We therefore classified PA into a binary variable
with ‘yes’ indicating any type of PA and ‘no’ to indicate
no physical activity.
Most studies in APCSC did not differentiate between
type-1 and type-2 diabetes, and hence the analyses
included all individuals with diabetes recorded at study
baseline on the basis of either self-report (Woodward et
al., 2003) or an oral glucose tolerance test (Lawes et al.,
2004), or both. Using the values for height and weight
measured at study baseline, BMI (Ni Mhurchu et al., 2004)
was computed as weight in kilograms divided by height
squared (kg/m2).  Some studies (3) additionally recorded
waist circumference (cm). At recruitment, data were also
collected on several risk factors, including blood pressure
(Lawes et al., 2003), and cholesterol (Zhang et al., 2003).
Analyses used individual participant data and were
restricted to individuals aged ≥20 years at enrolment. Cox
proportional hazard models, stratified by study and sex
and adjusted for age, were used to estimate hazard ratios
and 95% confidence intervals (CIs) associated with
putative risk factors both before and after adjustment for
other risk factors. Associations between quantitative
variables and colorectal cancer were assessed through
hazard ratios and corresponding 95%CIs for a standard
increment in each variable. Dose-response associations
were explored by categorising study participants into equal
quarters of continuous distributions. Due to the limited
number of events (92) in the studies that had information
on waist circumference, we did not examine the dose-
response association with waist. Tests for regional and sex
interactions were conducted by adding interaction terms
to the Cox model. Linear trend was explored through
analyses by quartiles. Confidence intervals were calculated
using the floating absolute risk method (Easton et al.,
1991).
Within prospective studies, values for risk factors
measured at study baseline will fluctuate due to several
factors, including measurement error or within-person
variability, resulting in an underestimation of the true
association with disease risk, which is termed "regression
dilution bias" (MacMahon et al.,1990). By using repeat
measurements of the risk factors from a sample of the total
study population, attenuation coefficients were derived
using a linear regression model that accounted for the
heterogeneity of variance between studies, within-subject
correlation, and the varying time intervals between
measurements (Rosner et al., 1990). Information on repeat
measures of blood pressure, total cholesterol, body mass
index, waist circumference and fasting glucose were
available on up to 16 studies for between one to seven
occasions with a median of four years (1 to 29 yrs) after
the baseline measurement. Regression attenuation
coefficients were calculated in this way for, fasting glucose
(1.6), body mass index (1.2) and waist circumference (1.4)
and used to adjust the continuous associations between
these risk factors and the risk of death from colorectal
cancer. The log relative risks and standard errors obtained
from Cox proportional hazard analysis were multiplied
by an attenuation coefficient to produce an estimate with
95% confidence intervals of the association between the
usual values of a risk factor with colorectal
cancermortality.
Results
The characteristics of the participants in the 33 cohort
studies within the APCSC that contributed to these
analyses are summarized in Table 1. In total, 539201 (35%
female) individuals with a median follow-up of 6.8 years,
and a mean age of 47 years, were included in the analysis.
The mean values for height and BMI, and the prevalence
of cigarette smoking, differed substantially between Asia
and ANZ but the mean prevalence of diabetes was similar
among cohorts from Asia and ANZ (Table 1).
Overall, there were 751 deaths from colorectal cancer
(62% in cohorts from ANZ), during 3.7 million person-
years of follow up (Table 2). The age-standardised
mortality rates for colorectal cancer were approximately
three times higher among individuals in ANZ compared
with Asia in both males and females: 41 versus 14 and 31
versus 12 per 100,000 person-years in males and females
from ANZ and Asia, respectively.
Age and colorectal cancer
The risk of colorectal cancer was strongly associated
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Table1. Study Characteristics Including Values of Risk Factors at Baseline
Country            Study    Baseline       No. of      Mean   Female Median CRC*   Mean      Mean     Diabetic     Current
                                                                     subjects      age        (%)       FU     deaths   Height      BMI         (%)      Smokers (%)
                                                                                      (years)           (years)                  (cm)      (kg/m2)           M        F
Australia Busselton 1966-81 7,767 44.9 52 26.5 109 167 24.6 3.4 44 24
Australia Canberra-Quean 1990-91   706 76.5 45 9.8 11 - - 6.7 12 9
beyan Longitudinal
Australia Long. Study 1992-93 1,610 78.1 48 4.6 4 163 26.0 8.3 8 8
of Aging
Australia Melbourne 1990-94 41,285 54.8 59 8.5 179 165 26.9 5.4 15 9
Australia National 1989-90 9,277 43.5 51 8.3 19 168 25.4 1.9 27 21
Heart Foundation
Australia Newcastle 1983-94 5,929 51.7 50 8.9 29 167 26.7 3.5 28 18
Australia Perth 1978-94 10,230 45.1 48 14.4 55 169 25.2 2.6 30 21
Australia WA AAAScreenees 1996-99 12,203 72.2 0 3.2 50 171 26.9 11.7 11 -
NZ Fletcher Challenge 1992-94 10,326 44.3 28 5.8 13 172 26.4 2.6 25 18
ANZ Subtotal 1966-99 99,333 53.4 45 8.3 469 167 26.3 5.2 20 14
China Anzhen 1991 8,378 53.8 55 4.3 4 162 23.9 - 51 10
China East Beijing 1977-94 1,128 43.8 51 17.1 5 165 23.6 5.6 47 11
China Guangzhou 1985-98  166,695 41.5 22 7.3 57 167 22.6 10.0 60 1
Occupational
China Huashan 1990-92 1,868 53.0 52 2.8 1 162 23.4 13.7 48 4
China Seven Cities Cohorts 1987 10,811 53.9 55 2.7 14 162 22.6 1.2 57 17
China Shanghai 1972-78 9,347 48.5 31 14.0 33 - - - 61 7
Factory workers
China Six Cohorts 1982-86 19,387 44.7 47 9.0 11 160 21.2 - 76 12
China Tianjin 1984 9,335 54.6 51 6.1 13 162 23.5 - 63 39
China Yunnan 1976 6,581 55.8 3 4.5 6 162 21.6 1.0 70 0
Hong Kong Hong Kong 1985-91 2,983 78.6 57 2.5 13 154 21.9 8.6 29 11
Japan Aita town 1980-83 1,130 50.8 59 16.4 2 156 22.6 3.4 66 2
Japan Akabane 1985-86 1,834 54.5 56 11.0 5 155 22.5 2.5 62 1
Japan Civil Service Workers 1990-92 9,240 46.7 33 6.7 9 162 22.5 1.8 51 11
Japan Hisayama 1961 1,601 56.1 56 24.6 18 151 21.6 - 76 17
Japan Miyama 1988-90 1,073 60.8 56 6.6 4 154 22.2 5.2 58 7
Japan Saitama 1986-90 3,615 54.5 62 11.0 8 154 22.4 1.7 63 8
Japan Shibata 1977 2,350 56.9 58 20.0 14 152 22.4 1.1 72 4
Japan Shigaraki Town 1991-97 3,730 57.1 59 4.4 6 156 22.5 7.2 59 8
Japan Shirakawa 1974-79 4,640 48.0 54 17.5 6 - 21.5 1.0 70 5
Singapore Singapore Heart 1982-97 2,321 40.7 49 14.6 4 160 23.5 11.5 40 3
Singapore Singapore NHS92 1992 3,305 39.2 52 6.2 4 161 23.3 9.7 35 3
South Korea KMIC 1992  160,242 44.0 33 4.0 35 165 23.0 7.7 58 0
Taiwan CVDFACTS 1988-96 5,729 47.2 55 6.0 8 160 23.5 2.7 48 1
Taiwan Kinmen 1993-97 2,545 63.2 49 2.9 2 160 23.4 8.7 50 5
Asia Subtotal 1961-98 439,868 44.9 32 6.4 282 164 22.8 6.4 59 5
Total 1961-99  539,201 46.5 35 6.8 751 165 23.7 6.0 53 7
NZ=New Zealand; ANZ=Australia and New Zealand; CPD=cigarettes per day for current smokers; m=males; f=females
Table 2. Crude and Age-standardized Mortality Rates for Colorectal Cancer by Sex and Region in the Asia
Pacific Cohort Studies Collaboration
Region                     Sex No. of subjects        Person-years        No. of Events     Crude         Age-standardized
                                                                                                                              mortality rate*      mortality rate (95% CI)*
ANZ Male 54,353 454,143 271 60 41 (35 - 48)
Female 44,980 466,834 198 42 31 (26 - 37)
Overall 99,333 920,977 469 51 36 (32 - 40)
Asia Male 297,776 1867,029 183 10 14 (12 - 16)
Female 142,092 923,023 99 11 12 (10 - 15)
Overall 439,868 2790,052 282 10 13 (12 - 15)
Total Male 352,129 2321,172 454 20 21 (19 - 23)
Female 187,072 1389,857 297 21 19 (17 - 22)
Overall 539,201 3711,029 751 20 20 (19 - 21)
*per 100,000 person-years, ANZ = Australia and New Zealand
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with age. Among individuals over the age of 65 years the
risk of  dying from the neoplasm was eight times that of
those individuals less than 55 years of age (HR 8.05, 95%
CI: 6.18 – 10.5). The association was approximately linear
in that for every extra 10 years of increase in age, the risk
of colorectal cancer more than doubled: HR 2.30, 95%
Figure 1. Multiple-adjusted Hazard Ratios and 95% Confidence Intervals for the Associations between Risk
Factors with Mortality from Colorectal Cancer in APCSC. a =the units of examining the associations for all variables are
given in brackets; b =regression attenuation coefficients were 1.2, 1.4, and 1.6 for fasting glucose, body mass index, waist circum-
ference, and fasting glucose respectively; c= adjusted for smoking, diabetes, and alcohol; d=adjusted for diabetes, BMI, and alco-
hol; e =adjusted for smoking, BMI and alcohol; f =adjusted for smoking, diabetes, and alcohol; g =adjusted for smoking, diabetes,
and BMI
Table 3. Hazard Ratios (95% CIs) for the Dose-Response Associations between Risk Factors and Mortality from
Colorectal Cancer
Risk Factor                          No of                          No of                         Adjusted for Age,                    Multiple-Adjusted
                                                Subjects                       Deaths                            Sex & Study
Cigarettes per day
Never smoked*   58,151 211 1 1a
<20cpd   11,088   32 1.34   (0.89-2.01) 1.38   (0.92-2.08)
≥20cpd   10,243   20 0.88   (0.53-1.47) 0.89  (0.54-1.48)
Blood glucose (mmol/L)
   <5.1* 108,778   52 1 1b
    5.1-5.4   34,960   54 0.92  (0.61-1.40) 0.93  (0.61-1.40)
    5.4-6.0   30,602   52 0.75  (0.49-1.15) 0.74  (0.48-1.14)
   ≥6.0   19,278   50 0.87  (0.57-1.35) 0.85  (0.55-1.32)
BMI (kg/m2)
   <20*   31,610   36 1 1c
   20-<25 173,408 181 1.01   (0.70-1.47) 1.02   (0.70-1.48)
   25-28   64,665 161 1.37   (0.92-2.02) 1.37   (0.93-2.04)
   ≥28   36,994 137 1.25   (0.83-1.88) 1.24   (0.83-1.87)
Height (cm)
   ≤158*   77,737 130 1 1c
   159-165   86,624 125 1.11   (0.84-1.46) 1.11   (0.85-1.47)
   166-172   89,930 141 1.39   (1.02-1.90) 1.40   (1.03-1.92)
   ≥173   52,721 121 1.54   (1.08-2.20) 1.57   (1.10-2.24)
* Reference group aAdjusted for diabetes, BMI, and alcohol; bAdjusted for smoking , BMI and alcohol; cAdjusted for smoking, diabetes and alcohol
Variab le a
Hazard ratio 
(95% CI) P value
Alcohol (Yes/No) 
Physical activity (Yes/No) 
Fasting blood glucose (1mmol/L) b
Diabetes (Yes/No) 
Cigarettes  smoking (5 per day)
Cigarette smoking (Yes/No) 
Waist circumference (2cm) b
Body mass index (2kg/m ≤) b
Height (5cm) 
0.6 1.0 1.5 2.0
1.10 (1.03 -1.18)c 0.006
1.06 (1.00 -1.11) c 0.04
1.00 (0.95 -1.07)c 0.96
1.43 (1.09 -1.88)d 0.01
1.00 (0.92 -1.09) d 0.99
1.26 (0.92 -1.73)e 0.16
1.02 (0.88 -1.18)e 0.82
0.77 (0.60 -0.98) f 0.03
0.90 (0.70 -1.17) g 0.45
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CI 2.10 – 2.55.  The strength of the relationship did not
differ significantly between the regions (p for interaction
= 0.58) or by sex (p for interaction = 0.24).
Body anthropometry and colorectal cancer
In analyses adjusted for age and gender, there was a
significant dose-response relationship between height and
mortality from colorectal cancer (p for trend = 0.011;
Figure 2), such that a 5 cm greater height was associated
with an approximate 10% (95% CI 3 - 18%). This
relationship was slightly strengthened after adjusting for
smoking and diabetes (Table 3).  Overall, individuals in
the highest quarter for height had about 50% greater risk
of mortality from colorectal cancer compared with those
in the lowest quarter. The relationship was also observed,
and of a similar magnitude, in cohorts from both Asia and
ANZ and in both sexes (both p-values for interaction >0.7).
After adjustment for current weight, however, the positive
relationship between height and fatal colorectal cancer
was attenuated and the dose-response relationship was
significantly weakened, such that the excess risk,
comparing individuals in the top to the bottom quarter,
was reduced to 30% (p for trend = 0.12; Figure 2).
There was some evidence of a continuous dose-
response relationship between BMI and mortality from
colorectal cancer: in a multiple adjusted analysis,
individuals in the highest quarter of BMI had an
approximate 25% greater risk compared with those in the
lowest quarter (Table 3; p for trend = 0.06).  Overall, for
every 2 kg/m2 increment in BMI (equivalent to about 5
kg extra weight) the risk of mortality from colorectal
cancer rose by 6% (95% CI: 0 – 11%). There was no
evidence to suggest that the association differed between
regions or by sex (both p-values for interaction >0.7).
Among the subgroup of 27,572 individuals (92 events)
with information on waist circumference, there was no
association between central obesity and risk of mortality
from colorectal cancer  (Figure 1).
Cigarette smoking, alcohol consumption and colorectal
cancer
In age-adjusted analyses, cigarette smoking was
associated with about 40% greater risk of colorectal cancer
compared with non-smokers (Figure 1). The association
was noticeably weaker in cohorts from Asia compared
with those from ANZ; HR 1.16 (95% CI 0.69 – 1.95)
versus HR 1.54 (95% CI 1.13 – 2.11), although the
difference was not statistically significant (p-value for
interaction = 0.36). Overall, there was no evidence of a
dose-response association (Table 3), nor was there any
evidence to suggest that smoking cessation was associated
with any reduction in the risk of colorectal cancer. Indeed,
individuals who reported to have stopped smoking at study
baseline had a non-significant greater risk of mortality
from colorectal cancer compared with current smokers;
HR 1.55 (95% CI 1.19 – 2.02) versus 1.34 (95% CI: 1.03
– 1.74), p-value = 0.27. The data were left-censored to
preclude the possibility of reverse causality, but the
estimates remained largely unaltered after excluding the
first five years of study follow up (data not shown).
As we lacked the necessary information to examine
the relationship between duration of smoking and fatal
colorectal cancer, we used duration of study follow up as
a proxy marker for the number of smoking years.  There
was some indication that increasing duration of study
follow up was associated with a greater risk of colorectal
cancer such that for every five years of follow up the risk
associated with smoking increased by 12%: (95% CI -
2% –29%; p = 0.11).  In a further subgroup analysis among
316663 individuals (515 deaths) there was no evidence
to suggest an association between alcohol consumption
and fatal colorectal cancer (Figure 1).
Diabetes, blood glucose and colorectal cancer
A diagnosis of diabetes at study baseline was
associated with a non-significant 31% (95%CI: -4%-80%)
greater risk of fatal colorectal cancer compared with
individuals without diabetes that was slightly weakened
by adjustment for potential confounders (Figure 1). The
magnitude of the association was similar in both regions
and in both sexes (both p-values for interaction > 0.1).
Among a smaller subgroup of individuals (n=193618) with
information on blood glucose, there was no evidence of a
dose-response association (Table 3).
Physical activity, alcohol consumption and colorectal
cancer
Based on a subsample of 94500 individuals (310
deaths) there was some evidence to suggest a protective
effect of physical activity on the risk of fatal colorectal
cancer.  In fully adjusted analyses, among those individuals
who reported participating in some form of physical
activity  at the study baseline, the risk of colorectal cancer
was  23% (95% CI: 2% - 40%) lower as compared with
those individuals who did not report doing any form of
physical activity (p=0.03; Figure 1). The relationship was
similar between regions (p = 0.97) and in both sexes (p =
0.07).
Figure 2.  Hazard Ratios (95% CI) for the Association
between Height (cm) and Mortality (quartiles) before
(solid line) and after (dashed line) Adjustment for
Current Weight
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Discussion
Findings from the current study, with individual
participant data on nearly 540,000 individuals, lend
support for a modest role of potentially modifiable risk
factors in the aetiology of fatal colorectal cancer in
ethnically diverse populations of the Asia-Pacific region.
In particular, being overweight, having diabetes and a low
level of physical activity were each compatible with an
increased risk of dying from the malignancy.  The
magnitude of each of these associations was largely in
agreement with findings from previous studies that were
conducted predominantly within Caucasian populations.
A previous meta-analysis of 20 observational studies
reported relative risks for incident colorectal cancer of
1.6 and 1.3 in men and women, respectively, within the
highest category of BMI compared with those in the lowest
category, respectively (Bianchini et al., 2002). Data from
the current study, indicating an approximate 25% greater
risk of fatal colorectal cancer among individuals within
the highest, compared to the lowest, 25% of BMI values
are compatible with this estimate, although there was no
evidence to suggest a stronger association in men
compared with women. In practical terms, a 2 unit
increment in BMI (which is equivalent to an approximate
10 kg increase in weight) would be associated with about
a 5% greater risk of dying from the disease. However,
given that we were unable to adjust for the effects of
various dietary constituents such as fruit, vegetable, fibre
and meat that are all potential risk factors for the disease,
it is possible that the association between BMI and fatal
colorectal disease is partly, or wholly, due to confounding.
A dose-response association between stature and fatal
colorectal cancer was observed such that individuals
within the top 25% of the height distribution had a 50%
significantly greater risk of dying from the neoplasm
compared with those in the lowest 25%. However, the
magnitude of the association was significantly attenuated
after adjustment for current weight and became more
similar to that obtained by a meta-analysis of more than
5000 events, which reported a 30% greater risk of incident
colorectal cancer among individuals in the top compared
to the bottom 20% for height (Howe et al., 1997).  As
discussed in a recent review article by Gunnell and
colleagues (Gunnell et al., 2001), a causal relationship
between height and colorectal cancer (and several other
site-specific cancers including breast and prostate) is
improbable, rather, height may serve as a biomarker for
some currently unknown genetic, or environmental risk
factors, such as post-natal nutrition or infection, that are
related both to skeletal growth and mutanogenesis.
Understanding such mechanisms that link height with
cancer risk could provide opportunities for novel
therapeutic intervention.
Data from the current study suggested that individuals
with diabetes have a 26% greater risk of dying from
colorectal cancer compared with individuals without
diabetes. Although this was not significant in this study,
the estimate here agrees exactly with the findings of a
meta-analysis of 15 studies which reported a relative risk
of 1.26 (95% CI 1.05 – 1.50) for the same association
(Larsson et al., 2005). The same meta-analysis reported
that diabetes conferred a slightly higher, 30%, increased
risk of fatal or non-fatal colorectal cancer.
Despite the inherent difficulties involved in accurately
measuring physical activity in epidemiological studies,
an inverse association between physical activity with
colorectal cancer, particularly colon cancer, has been
consistently reported (Colditz et al., 1997). A recent review
of the epidemiological evidence reported that the average
reduction in risk across studies was 40-50% among the
most physically active group compared with the least
active, which was independent of diet, BMI and other
potential confounders (Friedenreich, 2001). Furthermore,
a consistent dose-response relation has been demonstrated
with those exhibiting the highest level of activity being at
significantly lower risk of developing colon cancer
compared with the least active group (Colditz et al., 1997).
Our data also support a protective role of physical activity
against fatal colorectal cancer in populations of the Asia
Pacific region.  However, given the variety of methods
used to measure physical activity across studies in APCSC,
which necessitated the categorisation of physical activity
into a single variable with binary outcomes, it would be
inappropriate to draw any more inference regarding the
strength of the association from these data.
It is a matter of ongoing debate as to whether cigarette
smoking is a risk factor for colorectal cancer. Although
many studies (Giovannucci et al., 2001; Chao et al., 2000;
Surgeon General’s Report, 2004) published over the past
couple of decades have found a statistically significant
increased risk for colorectal cancer among smokers, the
strength of the association was relatively weak, ranging
from between 1.2 and 1.6. However, as most of these
studies were unable to control for physical activity or diet,
it is difficult to determine whether the observed
relationship between smoking and colorectal cancer is
causal or due to confounding.  Some commentators have
suggested that the lack of an association between smoking
and colorectal cancer observed by some studies, is due to
an extraordinary long induction period of more than 30
years. Data from the current study provide some support
to this latter theory.  Overall, smoking was positively
associated with fatal colorectal cancer, particularly in
cohorts from Australia and New Zealand that are at a much
later stage of the smoking epidemic compared with many
countries in Asia.  Moreover, there was also a positive
trend towards increased duration of follow up (as a proxy
for duration of smoking) with colorectal risk.  However,
the lack of a clear dose-response relationship between the
number of cigarettes smoked with colorectal risk, in
conjunction with no significant reduction in risk among
ex-smokers, and the inability to adjust for known
confounders of the relationship, reflects the current state
of uncertainty regarding the relationship between smoking
and colorectal cancer.
In addition to the lack of information on duration,
frequency and type of physical activity and alcohol
consumed, all of which would have diluted the strength
of any associations, there are several other limitations that
warrant discussion. The analyses were based on self-
reported cigarette and alcohol consumption, which may
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